Crowley Elizabeth 4
4 · Celldex Therapeutics, Inc. · Filed Jun 11, 2024
Insider Transaction Report
Form 4
Crowley Elizabeth
SR. VP & CPDO
Transactions
- Exercise/Conversion
Common Stock
2024-06-07$10.38/sh+7,500$77,850→ 16,574 total - Sale
Common Stock
2024-06-07$35.06/sh−15,000$525,873→ 9,074 total - Exercise/Conversion
Common Stock
2024-06-07$9.02/sh+7,500$67,624→ 24,074 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-07−7,500→ 76,500 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (7,500 underlying) - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-07−7,500→ 0 totalExercise: $9.02Exp: 2028-06-13→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.86 to $35.59 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
- [F3]As of June 13, 2022, the option is fully vested.